PARAMETRIC PORTFOLIO ASSOCIATES LLC - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 117 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$659,000
-51.7%
193,848
-46.5%
0.00%0.0%
Q2 2018$1,363,000
+22.1%
362,509
+32.8%
0.00%0.0%
Q1 2018$1,116,000
-26.2%
272,981
-16.1%
0.00%
-50.0%
Q4 2017$1,513,000
+11.1%
325,386
+69.6%
0.00%
+100.0%
Q3 2017$1,362,000
-3.0%
191,850
-1.2%
0.00%
-50.0%
Q2 2017$1,404,000
+18.1%
194,138
+0.6%
0.00%0.0%
Q1 2017$1,189,000
+68.4%
192,982
+60.1%
0.00%
+100.0%
Q4 2016$706,000
+460.3%
120,546
+408.5%
0.00%
Q3 2016$126,000
-26.7%
23,704
-8.7%
0.00%
Q2 2016$172,000
+49.6%
25,951
+5.4%
0.00%
Q1 2016$115,000
-12.9%
24,623
-5.9%
0.00%
Q4 2015$132,000
+78.4%
26,156
+24.9%
0.00%
Q3 2015$74,000
-85.1%
20,946
-57.7%
0.00%
-100.0%
Q2 2015$495,000
-40.5%
49,562
-24.1%
0.00%
-50.0%
Q1 2015$832,000
+13.0%
65,338
+25.6%
0.00%0.0%
Q4 2014$736,0000.0%52,038
-2.8%
0.00%0.0%
Q3 2014$736,000
-28.6%
53,552
-20.1%
0.00%0.0%
Q2 2014$1,031,000
-13.9%
67,019
-4.6%
0.00%
-33.3%
Q1 2014$1,197,000
+34.3%
70,245
+2.1%
0.00%
+50.0%
Q4 2013$891,000
+70.7%
68,768
+32.9%
0.00%
+100.0%
Q3 2013$522,000
+96.2%
51,729
+45.4%
0.00%0.0%
Q2 2013$266,00035,5740.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Old West Investment Management, LLC 1,068,719$3,633,0001.50%
Abrams Capital Management 9,108,867$30,970,0000.82%
Baupost Group 25,791,678$87,692,0000.67%
Bristol Advisors, LLC 51,100$174,0000.29%
RICE HALL JAMES & ASSOCIATES, LLC 2,228,059$7,575,0000.27%
NEXTHERA CAPITAL LP 200,000$680,0000.13%
LINCOLN CAPITAL CORP 37,280$127,0000.10%
Meridian Wealth Management, LLC 49,600$169,0000.07%
Rubric Capital Management LP 199,883$680,0000.07%
Virtus ETF Advisers LLC 155,009$527,0000.05%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders